Highlights
- Market Cap
- $492.06M
- Enterprise Value
- $571.64M
- EPS (TTM)
- $0.67
- PE Ratio
- 131.45
- Total Revenue (TTM)
- $247.54M
- Gross Profit (TTM)
- $150.03M
- EBITDA (TTM)
- $44.33M
- Year Range
- $55.45 - $131.20
- Target Price
- $83.00
- ROA (TTM)
- 0.86%
- ROE (TTM)
- 2.00%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Mesa Laboratories, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Mesa Laboratories, Inc. (MLAB) has returned 12.83% so far this year and -24.92% over the past 12 months. Over the last ten years, MLAB has returned -0.58% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
Mesa Laboratories, Inc.
- 1D
- 3.94%
- 1M
- -8.44%
- YTD
- 12.83%
- 6M
- 32.43%
- 1Y
- -24.92%
- 3Y*
- -19.82%
- 5Y*
- -18.28%
- 10Y*
- -0.58%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Aug 18, 1995, MLAB's average daily return is +0.08%, while the average monthly return is +1.41%. At this rate, your investment would double in approximately 4.1 years.
Historically, 56% of months were positive and 44% were negative. The best month was Nov 2005 with a return of +39.2%, while the worst month was Sep 2023 at -26.7%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.
On a daily basis, MLAB closed higher 45% of trading days. The best single day was May 23, 2007 with a return of +22.6%, while the worst single day was Jun 3, 2019 at -25.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.33% | 22.82% | -8.44% | 12.83% | |||||||||
| 2025 | 4.41% | 1.35% | -14.87% | -2.87% | -12.56% | -6.36% | -18.83% | -11.20% | -1.09% | 7.28% | 11.78% | -2.12% | -40.05% |
| 2024 | -12.55% | 19.35% | 0.49% | -3.33% | -9.65% | -9.33% | 31.98% | 16.88% | -2.86% | -12.18% | 2.86% | 12.57% | 26.56% |
| 2023 | 17.04% | -9.18% | -1.01% | -4.70% | -22.14% | -0.76% | 0.12% | 11.55% | -26.71% | -10.70% | -8.85% | 22.72% | -36.65% |
| 2022 | -13.34% | -10.14% | -0.18% | -16.18% | -1.98% | -2.54% | 4.57% | -19.80% | -17.58% | -6.12% | 28.08% | -1.75% | -49.18% |
| 2021 | -3.31% | -1.83% | -10.45% | 2.11% | -0.98% | 10.20% | 8.61% | -9.31% | 13.28% | 1.10% | 1.06% | 6.25% | 14.73% |
Benchmark Metrics
Mesa Laboratories, Inc. has an annualized alpha of 18.05%, beta of 0.41, and R² of 0.03 versus S&P 500 Index. Calculated based on daily prices since August 21, 1995.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (74.00%) than losses (53.03%) — typical of diversified or defensive assets.
- Beta of 0.41 may look defensive, but with R² of 0.03 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R² of 0.03 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 18.05%
- Beta
- 0.41
- R²
- 0.03
- Upside Capture
- 74.00%
- Downside Capture
- 53.03%
Return for Risk
Risk / Return Rank
MLAB ranks 25 for risk / return — below 25% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Mesa Laboratories, Inc. (MLAB) and compare them to a chosen benchmark (S&P 500 Index).
| MLAB | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.40 | 0.90 | -1.30 |
Sortino ratioReturn per unit of downside risk | -0.19 | 1.39 | -1.58 |
Omega ratioGain probability vs. loss probability | 0.97 | 1.21 | -0.24 |
Calmar ratioReturn relative to maximum drawdown | -0.46 | 1.40 | -1.86 |
Martin ratioReturn relative to average drawdown | -0.73 | 6.61 | -7.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore MLAB risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Mesa Laboratories, Inc. provided a 0.72% dividend yield over the last twelve months, with an annual payout of $0.64 per share. The company has been increasing its dividends for 18 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 |
Dividend yield | 0.72% | 0.82% | 0.49% | 0.61% | 0.39% | 0.20% | 0.22% | 0.26% | 0.31% | 0.51% | 0.52% | 0.64% |
Monthly Dividends
The table displays the monthly dividend distributions for Mesa Laboratories, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.16 | $0.00 | $0.16 | |||||||||
| 2025 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.64 |
| 2024 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.64 |
| 2023 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.64 |
| 2022 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.64 |
| 2021 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.64 |
Dividend Yield & Payout
Dividend Yield
Mesa Laboratories, Inc. has a dividend yield of 0.72%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Mesa Laboratories, Inc. has a payout ratio of 93.97%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Mesa Laboratories, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Mesa Laboratories, Inc. was 82.43%, occurring on Aug 5, 2025. The portfolio has not yet recovered.
The current Mesa Laboratories, Inc. drawdown is 72.79%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -82.43% | Dec 28, 2021 | 904 | Aug 5, 2025 | — | — | — |
| -64.81% | Jun 19, 1996 | 925 | Feb 16, 2000 | 963 | Dec 17, 2003 | 1888 |
| -43.7% | Jan 10, 2008 | 304 | Mar 25, 2009 | 193 | Dec 29, 2009 | 497 |
| -41.25% | Mar 24, 2014 | 128 | Sep 23, 2014 | 206 | Jul 20, 2015 | 334 |
| -34.53% | Aug 4, 2015 | 131 | Feb 9, 2016 | 81 | Jun 6, 2016 | 212 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Mesa Laboratories, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Mesa Laboratories, Inc. is priced in the market compared to other companies in the Scientific & Technical Instruments industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for MLAB, comparing it with other companies in the Scientific & Technical Instruments industry. Currently, MLAB has a P/E ratio of 131.4. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MLAB relative to other companies in the Scientific & Technical Instruments industry. Currently, MLAB has a P/S ratio of 2.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for MLAB in comparison with other companies in the Scientific & Technical Instruments industry. Currently, MLAB has a P/B value of 2.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |